|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
1F, Building 2, No.466, Yindu Rd, Shanghai, Shanghai 200231, CN
|
|
CARsgen is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company has built an integrated cell therapy platform with in-house capabilities that span target discovery, antibody development, clinical trials, and commercial-scale manufacturing. CARsgen has internally developed novel technologies and a product pipeline with global rights to address major challenges of CAR T-cell therapies, such as improving the safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs. Our vision is to become a global biopharmaceutical leader that brings innovative and differentiated cell therapies to cancer patients worldwide and makes cancer curable.
|
CARsgen Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{last}{first} | [email protected] |
75%
|
The widely used CARsgen Therapeutics email format is {last}{first} (e.g. [email protected]) with 75% adoption across the company.
To contact CARsgen Therapeutics customer service number in your country click here to find.
Zonghai Li is the CEO of CARsgen Therapeutics. To contact Zonghai Li email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.